Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone
about
Abiraterone in metastatic prostate cancer without previous chemotherapyGaleterone for the treatment of advanced prostate cancer: the evidence to dateEmerging mechanisms of resistance to androgen receptor inhibitors in prostate cancerAbiraterone in the management of castration-resistant prostate cancer prior to chemotherapyAbiraterone in the treatment of metastatic castration-resistant prostate cancerBeyond T and DHT - novel steroid derivatives capable of wild type androgen receptor activationRecent progress in pharmaceutical therapies for castration-resistant prostate cancerMolecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerAR-V7 and resistance to enzalutamide and abiraterone in prostate cancerEmerging data on androgen receptor splice variants in prostate cancerProstate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastasesThe combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory studyTruncation and constitutive activation of the androgen receptor by diverse genomic rearrangements in prostate cancer.Androgen receptor promotes ligand-independent prostate cancer progression through c-Myc upregulationAndrogen metabolism in prostate cancer: from molecular mechanisms to clinical consequencesCYP17 inhibitors--abiraterone, C17,20-lyase inhibitors and multi-targeting agents.Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axisCYP17A1 inhibitors in castration-resistant prostate cancerA phase 2 study of abiraterone acetate in Japanese men with metastatic castration-resistant prostate cancer who had received docetaxel-based chemotherapy.Molecular characterization of enzalutamide-treated bone metastatic castration-resistant prostate cancerAndrogenic biomarker prof|ling in human matrices and cell culture samples using high throughput, electrospray tandem mass spectrometry.Platelet-Synthesized Testosterone in Men with Prostate Cancer Induces Androgen Receptor SignalingManagement of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.Androgen deprivation therapy in castrate-resistant prostate cancer: how important is GnRH agonist backbone therapy?Androgen pathway resistance in prostate cancer and therapeutic implicationsAndrogen receptor targeting drugs in castration-resistant prostate cancer and mechanisms of resistanceRegulators of Androgen Action Resource: a one-stop shop for the comprehensive study of androgen receptor action.Minireview: Androgen metabolism in castration-resistant prostate cancer.Perspectives on treatment of metastatic castration-resistant prostate cancer.Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate CancerMolecular pathogenesis and progression of prostate cancerMolecular pathways: Inhibiting steroid biosynthesis in prostate cancer.ERG/AKR1C3/AR Constitutes a Feed-Forward Loop for AR Signaling in Prostate Cancer CellsSkeletal metastasis: treatments, mouse models, and the Wnt signaling.Targeted molecular-genetic imaging and ligand-directed therapy in aggressive variant prostate cancer.Castration-Resistant Prostate Cancer Tissue Acquisition From Bone Metastases for Molecular Analyses.Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.
P2860
Q24612084-7EECDD2D-CE16-4059-BEB8-DDA1524E76A6Q26739887-360AE1CF-E965-429A-80EC-3188EE0B7A2EQ26777310-CC93EFF4-BA2B-44A4-8EC7-BB1B6362F799Q26786543-81D7D9A7-191B-4B42-9E2D-7AAE09958B92Q26853635-CC518064-8EA8-4E8F-A6A1-58EC0FC088E7Q27007208-B733EE97-FC3C-478D-89D0-F2E01554629CQ27022567-D15F9082-EE98-42D1-BFA2-46F512B8250BQ27024775-55645EBB-F2B5-40B6-8246-CB7B0E7280C3Q27853062-9C923037-15EC-4539-BAC0-440040305BABQ28077830-E1C8AC9C-10F5-4E24-BD13-17CADCA3E481Q28247245-463CEBB7-7E5B-4783-B9AA-F64D708D0B48Q28388750-E21799CB-71F2-44B5-8CD5-BF0DD98ACCE9Q30831010-2552D965-8722-424D-AB3D-67A2FAA99396Q33390573-76CEFB39-6070-4DBD-9691-565ECB7B37ABQ34283623-A9FCEDAB-4FDB-4363-9790-BA8DFFB62F5CQ34387852-41871A88-A0D3-4FD8-B92B-43B9EADAC1D8Q34390313-EE3190C4-669C-40FE-A5D8-53D5E424A295Q34428508-875C8DC7-5866-4F57-B761-85226C9A82F3Q34456638-9BB84946-7E48-46E4-A8FC-E970BAF52D9BQ34569684-533743F2-D8E4-4E2B-BAD5-BC8F72B5BE6DQ34587744-3D988484-E54B-4EA5-AEF4-6A0380FC6B0EQ35105225-EADD9354-9032-4805-8BC7-74361C235B85Q35685518-D65EC958-4D6C-4BF6-A4D7-D74786BEA929Q35879087-1507EDDD-49D2-4C24-8444-E5DF17D6B835Q35881896-350F413F-EAAE-47A6-A59E-91E145201FB3Q36416370-9FE6B1C7-6950-485A-9DE5-501519C915A7Q36470627-A67DB347-B25F-4602-B741-8B6070430DCAQ36578330-DE906AA4-E80C-4E06-A3A1-46C9D40E7518Q36789277-221AAFF9-80B4-4A6F-9157-C194B9571BE4Q36871685-34F9C036-6B13-49ED-A7C1-059561B84CCFQ37009071-C32D6940-2E18-4722-A115-F4B121AC51A6Q37055715-B9FA5D13-F2C1-4D04-8763-77DD677265FEQ37076775-C1CBD633-269C-491E-865D-3E95DA99CDCAQ37157965-8F4F119C-0FCE-4423-99DE-F798243EAB38Q37354085-D03AE39E-2933-4C7B-B404-3590A61A43F6Q37417870-3E752698-F609-432E-AE69-40401DB1692AQ37462283-9E0D3C5F-34F6-48A6-AD03-1674F64FAF6FQ37496652-8774473D-2F72-4034-A392-FD32FD60E520Q37537958-D33BCAD1-AC03-4EEB-931C-A0724C0106D6Q37709535-7E473F93-31FD-4448-9242-0FCD172B818E
P2860
Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Effects of abiraterone acetate ...... istant prostate cancer in bone
@ast
Effects of abiraterone acetate ...... istant prostate cancer in bone
@en
type
label
Effects of abiraterone acetate ...... istant prostate cancer in bone
@ast
Effects of abiraterone acetate ...... istant prostate cancer in bone
@en
prefLabel
Effects of abiraterone acetate ...... istant prostate cancer in bone
@ast
Effects of abiraterone acetate ...... istant prostate cancer in bone
@en
P2093
P2860
P356
P1476
Effects of abiraterone acetate ...... istant prostate cancer in bone
@en
P2093
Arturo Molina
Christopher J Logothetis
Dimitra Tsavachidou
Eleni Efstathiou
Lisa A Smith
Maria Karlou
Mark Titus
Nicole Chieffo
Patricia Troncoso
P2860
P304
P356
10.1200/JCO.2010.33.7675
P407
P577
2011-12-19T00:00:00Z